Search Results for

New Test Announcement – Informed Pregnancy Screen

Effective March 1, 2016, PathGroup will offer Informed Pregnancy Screen, a non-invasive prenatal screen (NIPS) that analyzes cell-free DNA (cfDNA) using next-generation sequencing to determine if a pregnancy is at increased risk for certain chromosome aneuploidies. Informed Pregnancy Screen has an industry-leading ‘no-call’ rate of 0.1% and a personalized positive predictive value (PPV) is included on every positive result. The test can be performed as early as 10 weeks gestation and results will be available in approximately 1 week. Electronic ordering and results delivery is available to PathGroup clients and post-test genetic counseling is available to patients if desired.

Click Here to read more.

Urinalysis Testing and Reporting – Update

This change will take effect on February 15, 2016

Effective February 15, 2016, PathGroup will be implementing the following procedure for all Urinalysis testing in an effort to improve the turnaround times as well as to better manage healthcare costs.

Click Here to read more.

ARUP – Test Update

January 4, 2016

PathGroup has been notified by our reference laboratory partner, ARUP Laboratories, of a resulting issue affecting specific send out testing that was processed through their facility. A compliance statement on results released from August 14, 2014 through November 13, 2015 was omitted while performing an interface coding change to the following tests:

  • Giardia lamblia Antibodies by ELISA (GLABS)
  • Glutathione, Total (GLUTH)
  • Vitamin B5 (B5A)

The omission of the compliance statement did not affect the test result and all test results remain unchanged.

Click Here to read more.

FibroMeter – Test Update

January 4, 2016

PathGroup has been notified by our reference laboratory partner, ARUP Laboratories, that an incorrect unit of measure for Blood Urea Nitrogen (BUN) was reported using U/L instead of the correct unit of measure, mg/dL. BUN is a component of the FibroMeter assay (FIBROM) which ARUP Laboratories performs. Results were not affected by the associated incorrect unit of measure and all scores, classifications, and overall test result interpretations remain unchanged.

Click Here to read more.

CPT Code Changes – Update

This change will take effect on January 1, 2016

Effective January 1, 2016, the American Medical Association (AMA) will introduce numerous changes to current procedural terminology (CPT) codes that include 11 deleted codes, 28 new codes and 50 revised codes. To ensure you are properly reimbursed for laboratory services rendered, PathGroup recommends you implement these changes (along with any other applicable CPT code changes) into your practice’s billing and coding structure by January 1, 2016.

Click Here to read more.

CPT Code Changes – New Obstetrics Panel Update

This change will take effect on January 1, 2016

Effective January 1, 2016, the American Medical Association (AMA) will introduce numerous changes to current procedural terminology (CPT) codes that include 11 deleted codes, 28 new codes and 50 revised codes. As a result, a new Obstetrics panel that includes HIV testing will be added and will require the use of CPT code 80081. In order to bill this code all components of the panel must be performed. The added service for this new panel includes HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result (87389).

Click Here to read more.

PAI1 4G/5G – Test Update

This change will take effect December 15, 2015

Overview and Clinical Utility:

Effective December 15, 2015, the gene name Plasminogen Activator Inhibitor, Type 1 (PAI1) will change to Serpin Peptidase Inhibitor, Clade E, Member 1 (SERPINE1). The orderable test code, PAI, will not change, however PathGroup will update all applications and directories to reflect the revised test name and description outlined below. In addition, PathGroup will implement new test methodology by PCR followed by fragment length analysis.

Click Here to read more.

Trichomonas – Test Update

This change will take effect December 7, 2015

Overview and Clinical Utility:

Effective December 7, 2015 PathGroup Labs will no longer be performing wet mount testing or culture for Trichomonas vaginalis In order to provide our clients with the most up to date infectious disease testing methods. According to the 2015 Sexually Transmitted Diseases Treatment Guidelines recently published by the CDC, culture is no longer considered the gold standard method for diagnosing T. vaginalis infection with the advent of molecular detection methods.  Wet mount microscopic analysis suffers from extremely low sensitivity which can give rise to a high number of false negative results. PathGroup will continue to offer testing for Trichomonas vaginalis by the APTIMA assay.

Click Here to read more.

Hendersonville Patient Service Center

This change will take effect November 1, 2015

Effective November 1, 2015, PathGroup’s Patient Service Center located on New Shackle Island Road in Hendersonville will no longer accept patients. If you have laboratory specimens for PathGroup and are not on a regular courier schedule, please call Client Services at 888-474-5227 to arrange a special pickup after November 1, 2015.

Click Here to read more.

ICD-10 Implementation Go-Live

September 30, 2015

The Centers for Medicare and Medicaid Services (CMS) mandated conversion to the International Classification of Diseases 10th Revision (ICD-10) will go into effect tomorrow, October 1, 2015. For proper claims processing on October 1 and after, it is essential that clients submit the most accurate and complete ICD-10 diagnosis code(s) to avoid incident. Claims encoded using the ICD-9 code set for services performed after October 1 will not be accepted.

Click Here to read more.